In a mouse model of melanoma, Lund et al. showed that VEGF-C-activated lymphatic endothelial cells take up and cross-present tumor antigens, leading to dysfunctional activation of CD8+ T cells [27]. The gene discussed is VEGFC; the disease is neoplasm.